Related Experiment Videos
[Impacts of stroke clinics on the utilization of statins for secondary prevention of ischemic stroke]
Bei-li Shao1, Jie-li Geng, Yan-sheng Li
1Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
Insights
Stroke clinics significantly increase statin use for secondary prevention of ischemic stroke. This specialized care improves adherence to guidelines, unlike general clinics where statin usage remains low.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Context:
- Secondary prevention of ischemic stroke is crucial.
- Statin therapy is a cornerstone of stroke prevention.
- Current guidelines recommend statins for high-risk patients.
Purpose:
- To evaluate the impact of a dedicated stroke clinic on statin utilization.
- To compare statin usage in stroke clinic versus general clinic settings.
- To assess factors influencing statin prescription in ischemic stroke patients.
Summary:
- A retrospective analysis of 568 ischemic stroke patients revealed significant differences in statin usage.
- Patients attending stroke clinics had higher statin prescription rates (51.3%) compared to general clinics (7.6%).
- Stroke clinics demonstrated improved statin use in patients with and without hyperlipidemia, and those with high LDL-C levels.
Impact:
- Stroke clinics enhance the implementation of evidence-based secondary stroke prevention strategies.
- Specialized stroke care can bridge the gap between clinical guidelines and real-world practice.
- Improved statin use in stroke patients can lead to better long-term outcomes and reduced recurrence rates.
Objective:
To describe the impact of stroke clinic on the usage of statins for secondary prevention of ischemic stroke.
Methods:
Data about the demography, social economic status, personal histories, blood lipid profiles, and the status of the usage of statins from 568 serial ischemic stroke patients were retrospectively analysed.
Results:
A total of 51.3% patients followed up in stroke clinic (306 patients) and 7.6% patients followed up in general clinic (262 patients) were treated with statins. 71.6% patients with and 44.8% patients without hyperlipidemia in stroke clinics were taking statins, which were higher than that patients in the general clinics (27.1% and 2.0% respectively). The patients in the stroke clinics with high LDL-C level (>3.4 mmol/L) were more likely to be treated with statins than those with lower level (25.6% vs 14.7%, P=0.017).
Conclusions:
The rate of statins usage is extremely low in stroke patients followed up in a general clinic, but it can been improved greatly in a stroke clinic. Stroke clinic can narrow the gap between the clinical practice and the guideline for secondary prevention of ischemic stroke.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Ischemic Stroke l: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Stroke ll: Pathophysiology